Apogee Therapeutics, Inc., (Nasdaq: APGE), a clinical-stage biotechnology company advancing optimized, novel biologics with potential for best-in-class profiles in the largest inflammatory and ...

IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a leading precision medicine oncology company, will present initial data at their 10 ...

The iX3 is the first offshoot of the New Class, which offers generous ranges and ample charging power. BMW is also trying to revolutionize operation.

Punekar, M.D., assistant professor of medicine, NYU Langone, Perlmutter Cancer Center, will share data from the EVEREST-2 study (poster number P3.18.87) during the Clinical Trials in Progress session ...

A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies for solid tumors, today announced the presentation of early efficacy and ...

SAN FRANCISCO — AT&T agreed to pay a total of $177 million to settle a class action lawsuit about two "data incidents" from 2024. The incidents resulted in some customer data, including names, ...

The iX3 is the first offshoot of the New Class, which offers generous ranges and ample charging power. BMW is also trying to ...

If you were a Facebook user at some point in the past 15 years, you may be receiving a payment from the popular social media ...

Oral presentation will feature data demonstrating SCY-247 in vitro activity against C. auris strains, including isolates with mutations commonly ...

Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced the presentation of new findings on its ...